Literature DB >> 23339744

Thyroid hormone levels within reference range are associated with heart rate, cardiac structure, and function in middle-aged men and women.

Greet L Roef1, Youri E Taes, Jean-Marc Kaufman, Caroline M Van Daele, Marc L De Buyzere, Thierry C Gillebert, Ernst R Rietzschel.   

Abstract

BACKGROUND: Triiodothyronine (T3) has many effects on the heart, and marked changes in cardiac function and structure occur in patients with (subclinical) thyroid disease. We investigated whether between-subject variation in thyroid hormone levels within the euthyroid range is also associated with heart rate and echocardiographic heart function and structure.
METHODS: Subjects were selected from the Asklepios study (n=2524), a population-representative random sample of patients aged between 35 and 55 years, free from overt cardiovascular disease at baseline. Analyses were restricted to 2078 subjects (1013 women and 1065 men), not using antihypertensive or thyroid medication nor having antithyroperoxidase antibody levels above clinical cut-off or thyrotropin (TSH) levels outside the reference range. All subjects were phenotyped in-depth and underwent comprehensive echocardiography, including diastolic evaluation. Thyroid function parameters were determined by automated electrochemiluminescence.
RESULTS: Heart rate was robustly positively associated with (quartiles of) free T3 (FT3) and T3, both in subjects with TSH levels within reference (0.27-4.2 μU/L) and in narrow TSH range (0.5-2.5 μU/L; p<0.0001). FT3 and T3 were negatively associated with left ventricular (LV) end-diastolic volume but positively associated with relative wall thickness. Total T3 (TT3) was associated with enhanced ventricular contraction (as assessed by tissue Doppler imaging). Free thyroxine, FT3, and TT3 were positively associated with late ventricular filling, and TT3 was associated with early ventricular filling.
CONCLUSION: We have demonstrated a strong positive association between thyroid hormone levels within the euthyroid range and heart rate, and more subtle effects on cardiac function and structure. More specifically, we suggest a smaller LV cavity size (with increased relative wall thickness), an enhanced atrial and ventricular contraction, and LV relaxation with higher circulating thyroid hormones. These results illustrate that variation in thyroid hormone levels, even within the reference range, exerts effects on the heart.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23339744      PMCID: PMC3752520          DOI: 10.1089/thy.2012.0471

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  45 in total

Review 1.  Thyroid hormone action in the heart.

Authors:  George J Kahaly; Wolfgang H Dillmann
Journal:  Endocr Rev       Date:  2005-01-04       Impact factor: 19.871

2.  New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid.

Authors:  Juergen Kratzsch; Georg Martin Fiedler; Alexander Leichtle; Matthias Brügel; Susanne Buchbinder; Lothar Otto; Osama Sabri; Gert Matthes; Joachim Thiery
Journal:  Clin Chem       Date:  2005-06-16       Impact factor: 8.327

3.  Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades.

Authors:  K Umetani; D H Singer; R McCraty; M Atkinson
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study.

Authors:  J W A Smit; C F A Eustatia-Rutten; E P M Corssmit; A M Pereira; M Frölich; G B Bleeker; E R Holman; E E van der Wall; J A Romijn; J J Bax
Journal:  J Clin Endocrinol Metab       Date:  2005-08-30       Impact factor: 5.958

6.  Influence of age, gender, and serum triglycerides on heart rate in a cohort of asymptomatic individuals without heart disease.

Authors:  Rogério Silva de Paula; Ivana Antelmi; Marcos Antonio Vincenzi; Carmen D S André; Rinaldo Artes; Cesar José Grupi; Alfredo José Mansur
Journal:  Int J Cardiol       Date:  2005-11-02       Impact factor: 4.164

7.  The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality.

Authors:  G B Mensink; H Hoffmeister
Journal:  Eur Heart J       Date:  1997-09       Impact factor: 29.983

8.  The association of thyroid function with cardiac mass and left ventricular hypertrophy.

Authors:  Marcus Dörr; Birger Wolff; Daniel M Robinson; Ulrich John; Jan Lüdemann; Wieland Meng; Stephan B Felix; Henry Völzke
Journal:  J Clin Endocrinol Metab       Date:  2004-11-02       Impact factor: 5.958

9.  Heart rate and cardiovascular mortality: the Framingham Study.

Authors:  W B Kannel; C Kannel; R S Paffenbarger; L A Cupples
Journal:  Am Heart J       Date:  1987-06       Impact factor: 4.749

Review 10.  Physiological variations in thyroid hormones: physiological and pathophysiological considerations.

Authors:  D A Fisher
Journal:  Clin Chem       Date:  1996-01       Impact factor: 8.327

View more
  13 in total

1.  Variables Contributing to Thyroid (Dys)Function in Pregnant Women: More than Thyroid Antibodies?

Authors:  Flora Veltri; Kris Poppe
Journal:  Eur Thyroid J       Date:  2018-04-27

2.  Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

Authors:  Susanna C Larsson; Elias Allara; Amy M Mason; Karl Michaëlsson; Stephen Burgess
Journal:  Circ Genom Precis Med       Date:  2019-03

3.  Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects.

Authors:  Greet L Roef; Ernst R Rietzschel; Caroline M Van Daele; Youri E Taes; Marc L De Buyzere; Thierry C Gillebert; Jean-Marc Kaufman
Journal:  Thyroid       Date:  2013-11-14       Impact factor: 6.568

4.  Association of thyroid function with white coat hypertension and sustained hypertension.

Authors:  Peng Cai; Yan Peng; YuXi Chen; Li Li; Wei Chu; Yan Wang; Xukai Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-11       Impact factor: 3.738

5.  Thyroid Hormones within the Normal Range and Cardiac Function in the General Population: The EPIPorto Study.

Authors:  João Sérgio Neves; Ricardo Fontes-Carvalho; Marta Borges-Canha; Ana Rita Leite; Sandra Martins; Ana Oliveira; João Tiago Guimarães; Davide Carvalho; Adelino Leite-Moreira; Ana Azevedo
Journal:  Eur Thyroid J       Date:  2020-07-08

6.  Serum-Free Thyroxine Levels Were Associated with Pulmonary Hypertension and Pulmonary Artery Systolic Pressure in Euthyroid Patients with Coronary Artery Disease.

Authors:  Bingjie Wu; Jingjing Jiang; Minghui Gui; Lin Liu; Qiqige Aleteng; Shanshan Wang; Xiaojing Liu; Yan Ling; Xin Gao
Journal:  Int J Endocrinol       Date:  2017-06-22       Impact factor: 3.257

7.  Lessons from Randomised Clinical Trials for Triiodothyronine Treatment of Hypothyroidism: Have They Achieved Their Objectives?

Authors:  Rudolf Hoermann; John E M Midgley; Rolf Larisch; Johannes W Dietrich
Journal:  J Thyroid Res       Date:  2018-07-16

8.  Genome-wide meta-analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans.

Authors:  Anh N Do; Wei Zhao; Abigail S Baldridge; Laura M Raffield; Kerri L Wiggins; Sanjiv J Shah; Stella Aslibekyan; Hemant K Tiwari; Nita Limdi; Degui Zhi; Colleen M Sitlani; Kent D Taylor; Bruce M Psaty; Nona Sotoodehnia; Jennifer A Brody; Laura J Rasmussen-Torvik; Donald Lloyd-Jones; Leslie A Lange; James G Wilson; Jennifer A Smith; Sharon L R Kardia; Thomas H Mosley; Ramachandran S Vasan; Donna K Arnett; Marguerite R Irvin
Journal:  Mol Genet Genomic Med       Date:  2019-08-13       Impact factor: 2.473

9.  Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults.

Authors:  Venkatesh L Murthy; Ravi V Shah; Jared P Reis; Alexander R Pico; Robert Kitchen; Joao A C Lima; Donald Lloyd-Jones; Norrina B Allen; Mercedes Carnethon; Gregory D Lewis; Matthew Nayor; Ramachandran S Vasan; Jane E Freedman; Clary B Clish
Journal:  Circulation       Date:  2020-10-19       Impact factor: 29.690

10.  Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation.

Authors:  Alexander Teumer; Layal Chaker; Stefan Groeneweg; Yong Li; Celia Di Munno; Caterina Barbieri; Ulla T Schultheiss; Michela Traglia; Tarunveer S Ahluwalia; Masato Akiyama; Emil Vincent R Appel; Dan E Arking; Alice Arnold; Arne Astrup; Marian Beekman; John P Beilby; Sofie Bekaert; Eric Boerwinkle; Suzanne J Brown; Marc De Buyzere; Purdey J Campbell; Graziano Ceresini; Charlotte Cerqueira; Francesco Cucca; Ian J Deary; Joris Deelen; Kai-Uwe Eckardt; Arif B Ekici; Johan G Eriksson; Luigi Ferrrucci; Tom Fiers; Edoardo Fiorillo; Ian Ford; Caroline S Fox; Christian Fuchsberger; Tessel E Galesloot; Christian Gieger; Martin Gögele; Alessandro De Grandi; Niels Grarup; Karin Halina Greiser; Kadri Haljas; Torben Hansen; Sarah E Harris; Diana van Heemst; Martin den Heijer; Andrew A Hicks; Wouter den Hollander; Georg Homuth; Jennie Hui; M Arfan Ikram; Till Ittermann; Richard A Jensen; Jiaojiao Jing; J Wouter Jukema; Eero Kajantie; Yoichiro Kamatani; Elisa Kasbohm; Jean-Marc Kaufman; Lambertus A Kiemeney; Margreet Kloppenburg; Florian Kronenberg; Michiaki Kubo; Jari Lahti; Bruno Lapauw; Shuo Li; David C M Liewald; Ee Mun Lim; Allan Linneberg; Michela Marina; Deborah Mascalzoni; Koichi Matsuda; Daniel Medenwald; Christa Meisinger; Ingrid Meulenbelt; Tim De Meyer; Henriette E Meyer Zu Schwabedissen; Rafael Mikolajczyk; Matthijs Moed; Romana T Netea-Maier; Ilja M Nolte; Yukinori Okada; Mauro Pala; Cristian Pattaro; Oluf Pedersen; Astrid Petersmann; Eleonora Porcu; Iris Postmus; Peter P Pramstaller; Bruce M Psaty; Yolande F M Ramos; Rajesh Rawal; Paul Redmond; J Brent Richards; Ernst R Rietzschel; Fernando Rivadeneira; Greet Roef; Jerome I Rotter; Cinzia F Sala; David Schlessinger; Elizabeth Selvin; P Eline Slagboom; Nicole Soranzo; Thorkild I A Sørensen; Timothy D Spector; John M Starr; David J Stott; Youri Taes; Daniel Taliun; Toshiko Tanaka; Betina Thuesen; Daniel Tiller; Daniela Toniolo; Andre G Uitterlinden; W Edward Visser; John P Walsh; Scott G Wilson; Bruce H R Wolffenbuttel; Qiong Yang; Hou-Feng Zheng; Anne Cappola; Robin P Peeters; Silvia Naitza; Henry Völzke; Serena Sanna; Anna Köttgen; Theo J Visser; Marco Medici
Journal:  Nat Commun       Date:  2018-10-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.